Literature DB >> 12771537

Effluent CA 125 concentration in chronic peritoneal dialysis patients: influence of PD duration, peritoneal transport and PD regimen.

Andreas Fusshöller1, Bernd Grabensee, Jörg Plum.   

Abstract

In terms of the integrity of the peritoneal membrane in peritoneal dialysis (PD), the peritoneal mesothelial cells play a pivotal role since its monolayer constitutes the first line of the peritoneal membrane. Cancer antigen 125 (CA 125) is released by peritoneal mesothelial cells and correlates with the mesothelial cell mass in PD. Since its effluent concentration is easy to determine in chronic PD patients, CA 125 serves as an in vivo marker of biocompatibility. We performed a cross-sectional study to investigate the relation between PD duration, peritoneal transport and the PD regimen (CAPD/CCPD) on effluent CA 125 concentration in 22 chronic PD patients. We compared long-term (>6 months) with short-term PD treatment, patients with high small solute transport properties (MTAC >11 ml/min, d/p ratio of creatinine >0.72) to patients with low small solute transport and CAPD with APD patients. A peritoneal equilibration test was performed with 1.36% glucose. Dialysate/plasma (D/P) ratio and mass transfer area coefficient (MTAC) of creatinine were calculated and the 4-hour effluent concentration of CA 125 was determined. CA 125 tended to be lower in the long-term PD patients and also in APD patients, but statistical significance was missing. Effluent CA 125 was significantly increased in patients with an MTAC of creatinine >11 ml/min (40.2 +/- 11.2 vs. 20.7 +/- 1.2 U/ml) and in patients with a d/p ratio of creatinine >0.72 (48.2 +/- 11.0 vs. 21.6 +/- 1.6 U/ml). CA 125 and the d/p ratio of creatinine were positively correlated (r = 0.68). The positive correlation of CA 125 with peritoneal small solute transport especially in the early phase of PD treatment indicates an initial correlation of the mesothelial cell mass with the peritoneal surface area. A direct relation between the CA 125 concentration and peritoneal transport is unlikely. In our study the CA 125 effluent concentration tended to be lower in long-term PD patients and also in APD patients, possibly indicating a cell depletory influence of the conventional PD fluid. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771537     DOI: 10.1159/000070994

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  4 in total

1.  Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.

Authors:  Lynn Redahan; Andrew Davenport
Journal:  J Nephrol       Date:  2015-11-30       Impact factor: 3.902

2.  Dialysate CA125 levels in children on continuous peritoneal dialysis.

Authors:  Pinar Turhan; Lale Sever; Salim Caliskan; Ozgur Kasapcopur; Ayse Sever; Munire Hacibekiroglu; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2005-08-20       Impact factor: 3.714

Review 3.  Dialysate cancer antigen 125 in long-term peritoneal dialysis patients.

Authors:  Panida Ditsawanon; Ouppatham Supasyndh; Pornanong Aramwit
Journal:  Clin Exp Nephrol       Date:  2013-06-12       Impact factor: 2.801

4.  Monitoring of the peritoneal membrane.

Authors:  Dirk G Struijk
Journal:  NDT Plus       Date:  2008-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.